Published online Jun 28, 2025. doi: 10.4329/wjr.v17.i6.106682
Revised: April 17, 2025
Accepted: May 21, 2025
Published online: June 28, 2025
Processing time: 106 Days and 20.8 Hours
Accurate preoperative differentiation of benign and malignant thyroid nodules is critical for optimal patient management. However, conventional imaging modali
To develop a non-contrast computed tomography-based machine learning model integrating radiomics and clinical features for preoperative thyroid nodule classification.
This multicenter retrospective study enrolled 272 patients with thyroid nodules (376 thyroid lobes) from center A (May 2021-April 2024), using histopathological findings as the reference standard. The dataset was stratified into a training cohort (264 lobes) and an internal validation cohort (112 lobes). Additional prospective temporal (97 lobes, May-August 2024, center A) and external multicenter (81 lobes, center B) test cohorts were incorporated to enhance generalizability. Thyroid lobes were segmented along the isthmus midline, with segmentation reliability confirmed by an intraclass correlation coe
The extreme gradient boosting model demonstrated robust diagnostic performance across all datasets, achieving AUCs of 0.899 [95% confidence interval (CI): 0.845-0.932] in the training cohort, 0.803 (95%CI: 0.715-0.890) in inter
The non-contrast computed tomography-based radiomics-clinical fusion model enables robust preoperative thyroid nodule classification, with SHAP-driven interpretability enhancing its clinical applicability for persona
Core Tip: This study introduces a novel non-contrast computed tomography-based machine learning model integrating radiomics and clinical features with lobe segmentation for preoperative differentiation of benign and malignant thyroid nodules. Leveraging dual-center data and thyroid lobe segmentation, the extreme gradient boosting model demonstrated superior diagnostic accuracy and stability across diverse cohorts, outperforming traditional radiologist assessments. Key predictors, including radiomic score, age, and tumor size group, calcify and cystic, were showed through SHAP analysis, enhancing model interpretability. The approach offers a robust, non-invasive tool for personalized preoperative decision-making, with the potential to improve clinical management of thyroid nodules.